首页> 外国专利> Molecular methods to assess complications after a kidney transplant

Molecular methods to assess complications after a kidney transplant

机译:评估肾脏移植后并发症的分子方法

摘要

A method for screening a human individual for expression of an RNA associated with a complication following renal transplantation, the method comprising comparing expression of the RNA in a vesicle isolated from a subject's urine sample with expression of the RNA in a vesicle isolated from a urine sample of a donor without complications following renal transplantation, wherein the RNA associated with a complication following kidney transplantation is selected from the group consisting of AIF1, BTN3A3, CCL5, CD48, HAVCR1 and SLC6A6, wherein an increase in the expression of the individual's RNA compared to the expression of the donor's RNA indicates that the subject has a complication after renal transplantation when the increase exceeds a threshold, comparing the expression of the RNA in the vesicle that comes from the urine sample isolated, further comprising: (a) recovering the vesicle from the sample of the subject by passing the sample of the subject through a vesicle-retaining filter; (b) loading a lysis buffer onto the vesicle-retaining filter, thereby lysing the vesicle in order to release a vesicle-associated RNA, (c) quantifying the expression of the RNA associated with a complication following kidney transplantation in the vesicle-associated RNA by PCR.
机译:一种在肾脏移植后筛选与并发症相关的RNA表达的人的方法,该方法包括比较从受试者的尿液样品分离的囊泡中RNA的表达与从尿液样品分离的囊泡中RNA的表达。肾移植后无并发症的供体,其中与肾移植后并发症相关的RNA选自AIF1,BTN3A3,CCL5,CD48,HAVCR1和SLC6A6,其中与捐献者RNA的表达表明当肾移植后增加超过阈值时受试者患有并发症,比较来自分离的尿液样品的囊泡中RNA的表达,还包括:(a)从通过使受试者的样品通过囊泡固定物使受试者的样品er; (b)将裂解缓冲液加载到囊泡保留滤器上,从而裂解囊泡以释放与囊泡相关的RNA,(c)量化与肾脏移植后并发症相关的RNA在囊泡相关RNA中的表达通过PCR。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号